Sri Lanka anti-COVID-19 measures to cost $550 million: Jayasundera

Sri Lanka’s anti-Covid-19 measures including vaccination, tests, and oxygen is expected to cost 550 million US dollars and more than 80 percent will be financed by the World Bank and Asian Development Bank, President’s Secretary P B Jayasundera said.

https://economynext.com/sri-lanka-anti-covid-19-measures-to-cost-550-million-jayasundera-86254/

economynext

2021-09-17

Related News and Insights

SriLankan loses Rs. 12.9 b in Q1

SriLankan Airlines recorded a Rs. 12.9 billion net loss in Q1 FY25, driven by cash flow challenges, legacy issues, and financial costs from past debt. ...

Find Out More

SL pays $ 503 m for 1H debt servicing

By June 2024, Sri Lanka's external debt had reached $37.5 billion, with $8.19 billion in unpaid debt service accumulating since the April 2022 debt standstill on bilateral and commercial loans.

Find Out More

Workers’ remittances decline in September

In September 2024, Sri Lanka’s remittances reached $556 million, tourism earnings were $181 million, and gross official reserves rose to $6 billion, covering 3.9 months of imports.

Find Out More

View All